Cargando…
Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a genetic disease characterised by skeletal muscle degeneration and progressive muscle wasting, which is caused by loss-of-function mutations in the DMD gene that encodes for the protein dystrophin. Dystrophin has critical roles in myofiber stability and integrit...
Autores principales: | Dumont, Nicolas A, Rudnicki, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703417/ https://www.ncbi.nlm.nih.gov/pubmed/29188075 http://dx.doi.org/10.1038/npjregenmed.2016.6 |
Ejemplares similares
-
Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
por: Kodippili, Kasun, et al.
Publicado: (2023) -
Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2021) -
A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy—Not Just a Muscle Defect
por: Coles, Chantal A., et al.
Publicado: (2022) -
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)